Upper Extremity Injection of Xeomin® and Changes in Gait Related Mobility in Adults After Stroke
Latest Information Update: 31 Jan 2024
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Muscle spasticity; Paresis
- Focus Therapeutic Use
- 25 Jan 2024 Planned End Date changed from 1 Apr 2024 to 1 Apr 2026.
- 25 Jan 2024 Planned primary completion date changed from 1 Apr 2024 to 1 Apr 2026.
- 02 Jun 2023 Planned End Date changed from 1 May 2023 to 1 Apr 2024.